Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_assertion type Assertion NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_head.
- NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_assertion wasGeneratedBy ECO_0000203 NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_provenance.
- NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_assertion wasDerivedFrom befree-20150227 NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_provenance.
- NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_assertion SIO_000772 20041183 NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_provenance.
- NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_assertion evidence source_evidence_literature NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_provenance.
- NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_assertion description "[Leucocyte activating chemokines such as CCL2, CCL3, and CXCL8 together with proinflammatory IFNgamma, TNFalpha and downmodulatory IL10 play a central role in the restriction of M. tuberculosis infections, but is unclear whether these markers are indicative of tuberculosis disease severity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685292.RA-nkU3Zx0DRn2E9-N8d7bClQRgeDltGTBR6WroJrfO70130_provenance.